Amrubicin hydrochlorideProduct ingredient for Amrubicin

Name
Amrubicin hydrochloride
Drug Entry
Amrubicin

Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January 2005, Amrubicin has been marketed by Nippon Kayaku, a Japanese pharmaceutical firm focused on oncology, which licensed Japanese marketing rights from Dainippon Sumitomo, the original developer of Amrubicin 13,15.

Accession Number
DBSALT001934
Structure
Synonyms
Calsed
External IDs
SM 5887 / SM-5887
UNII
EUL6MP8FZW
CAS Number
110311-30-3
Weight
Average: 519.93
Monoisotopic: 519.1296091
Chemical Formula
C25H26ClNO9
InChI Key
BHMLHEQFWVQAJS-IITOGVPQSA-N
InChI
InChI=1S/C25H25NO9.ClH/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31;/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3;1H/t14-,15+,16-,17-,25-;/m0./s1
IUPAC Name
(7S,9S)-9-acetyl-9-amino-7-{[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy}-6,11-dihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride
SMILES
Cl.[H][C@@]1(C[C@H](O)[C@H](O)CO1)O[C@H]1C[C@@](N)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=CC=CC=C1C3=O)C(C)=O
ChemSpider
102849
ChEMBL
CHEMBL481958
Predicted Properties
PropertyValueSource
Water Solubility1.14 mg/mLALOGPS
logP1.4ALOGPS
logP1.74Chemaxon
logS-2.6ALOGPS
pKa (Strongest Acidic)8.1Chemaxon
pKa (Strongest Basic)7.02Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count10Chemaxon
Hydrogen Donor Count5Chemaxon
Polar Surface Area176.61 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity122.01 m3·mol-1Chemaxon
Polarizability49.03 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon